Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia

Fadima C. Haidara; Ama Umesi; Samba O. Sow; Magnus Ochoge; Fatoumata Diallo; Abdulazeez Imam; Youssouf Traore; Lucy Affleck; Moussa F. Doumbia; Bubacarr Daffeh; Mamoudou Kodio; Oghenebrume Wariri; Awa Traoré; Edrissa Jallow; Beate Kampmann; Dhananjay Kapse; Prasad S. Kulkarni; Asha Mallya; Sunil Goel; Pankaj Sharma; Annamraju D. Sarma; Nikhil Avalaskar; F. Marc LaForce; Mark R. Alderson; Abdi Naficy; Steve Lamola; Yuxiao Tang; Lionel Martellet; Nancy Hosken; Evangelos Simeonidis; Jo Anne Welsch; Milagritos D. Tapia; Ed Clarke

Journal ArticleOPEN ACCESS

Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia

Haidara F
Umesi A
Sow S
et al.

New England Journal of Medicine (2023) 388(21) 1942-1955

DOI: 10.1056/nejmoa2214924

40Citations

70Readers

Abstract

Abstract Background An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and immunogenic...

Cite

CITATION STYLE

APA

Haidara, F. C., Umesi, A., Sow, S. O., Ochoge, M., Diallo, F., Imam, A., … Clarke, E. (2023). Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia. New England Journal of Medicine, 388(21), 1942–1955. https://doi.org/10.1056/nejmoa2214924

Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia

Abstract

Cite

Register to see more suggestions